The Clinical Outcome of Prospective Screening for Multiple Endocrine Neoplasia Type 2A
- 25 February 1988
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 318 (8) , 478-484
- https://doi.org/10.1056/nejm198802253180804
Abstract
An important question facing physicians who care for families with multiple endocrine neoplasia type 2a is whether prospective screening to detect early abnormalities of the thyroid, parathyroid, or adrenal glands favorably influences the ultimate course of the disease. An 18-year study of a large family has allowed us to examine the effect of early treatment on the clinical course of the disease.This publication has 30 references indexed in Scilit:
- Catecholamine Release after Physical ExerciseActa Medica Scandinavica, 1987
- Parathyroid Mitogenic Activity in Plasma from Patients with Familial Multiple Endocrine Neoplasia Type 1New England Journal of Medicine, 1986
- Secretion of Chromogranin A by Peptide-Producing Endocrine NeoplasmsNew England Journal of Medicine, 1986
- Age-related probability of development of hereditary medullary thyroid carcinomaThe Journal of Pediatrics, 1982
- Medullary carcinoma of the thyroid in the multiple endocrine neoplasia IIA syndromeThe American Journal of Surgical Pathology, 1981
- Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia type IIThe American Journal of Medicine, 1978
- Natural History of Familial Medullary Thyroid CarcinomaNew England Journal of Medicine, 1978
- Total thyroidectomy for occult familial medullary carcinoma of the thyroid in childrenJournal of Pediatric Surgery, 1976
- A RADIOIMMUNOASSAY FOR HUMAN CALCITONIN MThe Lancet, 1969
- The Fallacy of the Conventional Radical Neck Dissection for Papillary Carcinoma of the ThyroidAnnals of Surgery, 1957